2217 GMT - The a2 Milk Company's bull at Citi is even more positive on the infant-formula manufacturer's local-label prospects in China following a visit to the country. Analyst Sam Teeger tells clients in a note that manufacturing dates on tins are relatively more recent than those he saw a year ago, which he takes as a sign of underlying product sell-through. He acknowledges that he only visited 10 supermarkets and baby stores, but says that this evidence is consistent with recent port data. Citi has a buy rating and A$7.33 target price on the stock, which is at A$5.78 ahead of the open. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
February 11, 2025 17:17 ET (22:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.